Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer
Sign Up to like & getrecommendations! Published in 2017 at "Science Signaling"
DOI: 10.1126/scisignal.aal2328
Abstract: Targeting TNF receptor type 2 may be a new avenue for treating ovarian cancer (Torrey et al., in 17 January 2017 issue). Tumor necrosis factor receptor 2 (TNFR2) is expressed both by some cancer cells… read more here.
Keywords: immune checkpoint; targeting tnfr2; tnfr2; tnfr2 immune ... See more keywords
Targeting TNFR2 in Cancer: All Roads Lead to Rome
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.844931
Abstract: TNF receptor 2 (TNFR2) has become one of the best potential immune checkpoints that might be targeted, mainly because of its vital role in tumor microenvironments (TMEs). Overexpression of TNFR2 in some tumor cells and… read more here.
Keywords: cancer; tnfr2 cancer; tnfr2; targeting tnfr2 ... See more keywords